|
Market Closed -
Nasdaq
06:00:00 01/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 19.04 USD | -1.09% |
|
-8.20% | +10.86% |
| 23/09 | Top Midday Gainers | MT |
| 23/09 | Omeros Shares Rise After Cantor Fitzgerald Upgrade | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.38B | - | - | - | - | |
| 74.46B | |||||
| 60.14B | |||||
| 48.15B | |||||
| 44.25B | |||||
| 43.99B | - | - | - | - | - |
- Stock Market
- Stocks
- OMER Stock
- Charts Omeros Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
